SQI Diagnostics Announces Agreement with Isis Pharmaceuticals
October 31, 2013
TORONTO -- SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”) today announced that they have entered into a method development agreement with Isis Pharmaceuticals (Isis) to develop a multiplexed assay that will utilize SQI’s Ig_PLEX™ multiplexing immunogenicity technology. “SQI [...]
TECHNE CORPORATION DECLARES DIVIDEND
October 31, 2013
Minneapolis - Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.31 per share for the quarter ended December 31, 2013. The quarterly dividend will be payable February 28, 2014 to all common shareholders of record on February 14, 2014. Future cash dividends will be considered by the [...]
Tute Genomics Launches at 2013 ASHG Conference
October 31, 2013
Salt Lake City, UT -- Tute Genomics made their public debut last week at the 2013 American Society for Human Genetics (ASHG) conference in Boston, MA. Tute, founded in 2012, is a cloud-based, professional grade clinical genome interpretation engine that has the ability to analyze and annotate entire human genomes in a rapid and cost-effective [...]
October 31, 2013
WALTHAM, Mass.--- PerkinElmer, Inc., a global leader in improving the health and safety of people and the environment, today introduced the DairyGuard™ milk powder analyzer, a near infrared (NIR) spectrometer specifically developed for food suppliers and manufacturers. DairyGuard is the only system available that tests for unknown adulterants as well as known compounds, such as [...]
October 31, 2013
MEMPHIS, Tenn.---- Meridian Life Science, Inc., (MLS) of Memphis, Tennessee, a wholly-owned subsidiary ofMeridian Bioscience, Inc. (NASDAQ:VIVO), has been selected by the Centers for Disease Control and Prevention (CDC) to develop a process for manufacture of a rotavirus vaccine. Funding for this activity will be provided through a Small Business Innovation Research (SBIR) contract. Process [...]
Arrayit Corporation Receives Contract Award From the Department of Veterans Affairs
October 31, 2013
SUNNYVALE, Calif. -- Arrayit Corporation (OTCBB:ARYC), a life sciences and molecular diagnostics leader, announces today a $39,590 contract award from the United States Department of Veteran Affairs (VA). The VA Healthcare System provides some of the world's finest medicine and cutting-edge technology, as well as a teaching hospital, a full range of patient care services [...]
Illumina Announces Organizational Changes and Exits PCR Market
October 31, 2013
Washington, DC 10/16/13; San Diego, CA 10/21/13—Illumina had made two announcements about its future. On its third quarter conference call, the company said it is exiting the qPCR market. The company provides the Eco qPCR instrument and NuPCR assays. “This decision was due in part to our belief that sequencing delivers advantages over qPCR technology [...]
October 31, 2013
CREEDMOOR, NORTH CAROLINA – AirClean® Systems microprocessor-controlled PCR workstations reduce risk of sample contamination during DNA/RNA amplification. AirClean® Systems AC600 Series PCR workstations are designed as application solutions for the manipulation and amplification of DNA and RNA. These PCR workstations are available in 24’’, 32’’, and 48’’ widths. Additional features include built-in 254 nm ultraviolet [...]
October 30, 2013
Modiquest Research, Oss, The Netherlands: ModiQuest Research BV, the Dutch antibody generation services company, today announced that it has entered into a research collaboration with the Beckman Research Institute of the City of Hope (“BRICOH”) aimed at the generation of novel monoclonal antibodies against a target selected by and proprietary to BRICOH. During the collaboration, [...]
PathoGenetix Announces $10 Million Series C Financing
October 30, 2013
Woburn, MA -- PathoGenetix™, Inc., a commercial-stage developer of an automated system for rapid bacterial identification, announced today that it has secured $10 million in a Series C financing to fund continued efforts to commercialize its Genome Sequence Scanning™ (GSS™) technology. The commitment was received from existing investors including Ascension Health Ventures, Excel Venture Management [...]
